Ocul stock premarket

OCUL: Get the latest Ocular Therapeutix stock price and detailed information including OCUL news, historical charts and realtime prices. OCUL Extended Hours. OCUL PreMarket. (). volume: as of AM. OCUL After Hours. (). volume: as of. Quote · Premarket · Options · Chart · Insiders · Financials  

Ocular Therapeutix (NASDAQ:OCUL) Ratings | Benzinga Jan 01, 2010 · Ocular Therapeutix (NASDAQ: OCUL) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers on Ocular Therapeutix, Inc. - OCUL - Stock Price Today - Zacks View Ocular Therapeutix, Inc. OCUL investment & stock information. Get the latest Ocular Therapeutix, Inc. OCUL detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. OCUL Ocular Therapeutix — Stock Price and Discussion ... Securities products and services offered to self-directed investors through ST Invest, LLC. Member FINRA / SIPC.ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal. Please read important legal disclosures. Premarket analyst action - healthcare - Ocular Therapeutix ...

OCUL | Stock Snapshot - Fidelity

OCUL | Ocular Therapeutix Inc. Profile | MarketWatch Nov 07, 2019 · Ocular Therapeutix Inc. company facts, information and stock details by MarketWatch. View ocul business summary and other industry information. Ocular Therapeutix, Inc. (OCUL) Market Stream - NASDAQ.com Social media updates, opinions, and reactions on Ocular Therapeutix, Inc. (OCUL) aggregated in real time from around the web on NASDAQ.com OCUL Stock | OCULAR THERAPEUTIX Stock Price Today ... OCUL: Get the latest Ocular Therapeutix stock price and detailed information including OCUL news, historical charts and realtime prices. OCUL - Ocular Therapeutix Summary, Stock Quote ... - Benzinga

Nov 07, 2019 · Ocular Therapeutix Inc. company facts, information and stock details by MarketWatch. View ocul business summary and other industry information.

Historical Data for Ocular Therapeutix Inc. (OCUL) Mar 18, 2020 · Date: Open: High: Low: Close: Volume: Chg % Chg: Adj. Close: Trade Val # Trades: 03/18/20: 4.74: 5.24: 4.14: 4.65: 1.62m-0.35-7.00%: 4.65: 7.5m: 9,394: 03/17/20: 4.21

Ocular Therapeutix Earnings Release Date - OCUL ...

Jan 04, 2017 · OcularTherapeutix, Inc. – Nasdaq: OCUL. Bedford, MA-based Ocular Therapeutix, Inc. shares are up over 8% in pre-market trading. Traded on the Nasdaq under ticker OCUL, the shares are benefitting from positive news that additional positive secondary endpoint results were reached from its most recent successful phase 3 clinical trial of Dextenza™ (dexamethasone insert) 0.4 mg, for the OCUL Stock Price, Forecast & News (Ocular Therapeutix) Researching Ocular Therapeutix (NASDAQ:OCUL) stock? View OCUL's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings at MarketBeat. TXMD TherapeuticsMD Inc. — Stock Price and ... - StockTwits

Jan 01, 2010 · Ocular Therapeutix (NASDAQ: OCUL) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers on

OCUL - Ocular Therapeutix Inc Stock quote - CNNMoney.com Find real-time OCUL - Ocular Therapeutix Inc stock quotes, company profile, news and forecasts from CNN Business. ProShares Ultra Bloomberg Crude (UCO) Stock Price, Quote ... Find the latest ProShares Ultra Bloomberg Crude (UCO) stock quote, history, news and other vital information to help you with your stock trading and investing. Ocular Therapeutix (NASDAQ:OCUL) Ratings | Benzinga Jan 01, 2010 · Ocular Therapeutix (NASDAQ: OCUL) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers on Ocular Therapeutix, Inc. - OCUL - Stock Price Today - Zacks

Why Ocular Therapeutix Inc Stock Jumped Higher Today | The ... Why Ocular Therapeutix Inc Stock Jumped Higher Today OCUL) stock is up 9.7% as of 11:41 a.m. EDT after the company presented phase 3 data for eye pain drug Dextenza. (OCUL) Q4 2018 All News for OCUL : Ocular Therapeutix, Inc. - Zacks.com